PharmaBiome is a privately-held spin-off company from ETH Zurich specializing in the production of live biotherapeutic products to address gut microbiome disturbances. The company has developed a first-in-the-industry, patent-protected technology platform for producing standardized microbiome-based products. Founded in Zurich in 2015 at the convergence of microbiology, biotechnology, and data science, PharmaBiome aims to devel...
PharmaBiome is a privately-held spin-off company from ETH Zurich specializing in the production of live biotherapeutic products to address gut microbiome disturbances. The company has developed a first-in-the-industry, patent-protected technology platform for producing standardized microbiome-based products. Founded in Zurich in 2015 at the convergence of microbiology, biotechnology, and data science, PharmaBiome aims to develop the biotechnology necessary for producing microbiome-based therapeutics that comply with the safety, efficiency, and trial requirements of human medicine.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.